As of 3:59pm ET
| -0.08 / -0.10%|
The 14 analysts offering 12-month price forecasts for ResMed Inc have a median target of 76.97, with a high estimate of 84.75 and a low estimate of 55.00. The median estimate represents a -2.30% decrease from the last price of 78.79.
The current consensus among 18 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.